Information Provided By:
Fly News Breaks for July 22, 2016
ATHN
Jul 22, 2016 | 06:12 EDT
Piper Jaffray analyst Sean Wieland says he's a buyer of athenahealth shares on weakness following the company's weaker than expected Q2 results. While the company "missed quarterly estimates in a big way," it reiterated guidance and "steered estimates to the upper end of the range, and likely did well on bookings," Wieland tells investors in a post-earnings research note. He keeps an Overweight rating on the shares with a $174 price target.
News For ATHN From the Last 2 Days
There are no results for your query ATHN